TY - JOUR
T1 - Stakeholders' views of the implementation of pharmacist prescribing in the community pharmacy setting: a mixed-methods systematic review
AU - Colthorpe, Anna
AU - Fleming, Aoife
AU - McCarthy, Suzanne
AU - McManus, Eimear
AU - Keating, John J.
AU - Dalton, Kieran
N1 - Publisher Copyright:
© 2026 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
PY - 2026/9/19
Y1 - 2026/9/19
N2 - Background: Pharmacist prescribing in community pharmacies is gaining traction globally as a strategy to enhance medication access. However, uptake remains inconsistent, making it essential to understand stakeholder perspectives to identify factors shaping successful implementation. Aim: To synthesise the views, experiences, perceived benefits, concerns, and contextual influences of key stakeholders regarding pharmacist prescribing in community pharmacies across implementation stages. Method: A mixed-methods systematic review using a convergent integrated approach was conducted. Five databases were searched from inception to March 2025. Primary research studies were included where ≥1 key study focus was on stakeholders' views of pharmacist prescribing in community pharmacies. Thematic synthesis was used to generate themes. Results: Five analytical themes explained variation in implementation: (1) support, motivation, and clinical readiness; (2) structural, policy, and organisational conditions shaping feasibility; (3) patient-centred access, continuity, and therapeutic relationships; (4) moral responsibility, risk, and safe practice boundaries; and (5) professional identity, autonomy, and legitimacy. Overall, the literature reflected support for pharmacist prescribing, particularly for low-risk, protocol-driven conditions and collaborative care models, although views varied across stakeholder groups and contexts. Perceived benefits included improved medication access, adherence, convenience, and patient satisfaction. Concerns remained regarding accountability, medico-legal risk, care fragmentation, workload, reimbursement, and commercial conflicts of interest. Confidence, training, interprofessional collaboration, and access to records strongly influenced implementation. Conclusion: Pharmacist prescribing is shaped by interacting individual, organisational and system-level factors. Sustainable implementation requires integrated care models, workforce development, governance frameworks, and supportive policy. This review offers actionable insights for policymakers and healthcare systems seeking to integrate pharmacist prescribing into routine care.
AB - Background: Pharmacist prescribing in community pharmacies is gaining traction globally as a strategy to enhance medication access. However, uptake remains inconsistent, making it essential to understand stakeholder perspectives to identify factors shaping successful implementation. Aim: To synthesise the views, experiences, perceived benefits, concerns, and contextual influences of key stakeholders regarding pharmacist prescribing in community pharmacies across implementation stages. Method: A mixed-methods systematic review using a convergent integrated approach was conducted. Five databases were searched from inception to March 2025. Primary research studies were included where ≥1 key study focus was on stakeholders' views of pharmacist prescribing in community pharmacies. Thematic synthesis was used to generate themes. Results: Five analytical themes explained variation in implementation: (1) support, motivation, and clinical readiness; (2) structural, policy, and organisational conditions shaping feasibility; (3) patient-centred access, continuity, and therapeutic relationships; (4) moral responsibility, risk, and safe practice boundaries; and (5) professional identity, autonomy, and legitimacy. Overall, the literature reflected support for pharmacist prescribing, particularly for low-risk, protocol-driven conditions and collaborative care models, although views varied across stakeholder groups and contexts. Perceived benefits included improved medication access, adherence, convenience, and patient satisfaction. Concerns remained regarding accountability, medico-legal risk, care fragmentation, workload, reimbursement, and commercial conflicts of interest. Confidence, training, interprofessional collaboration, and access to records strongly influenced implementation. Conclusion: Pharmacist prescribing is shaped by interacting individual, organisational and system-level factors. Sustainable implementation requires integrated care models, workforce development, governance frameworks, and supportive policy. This review offers actionable insights for policymakers and healthcare systems seeking to integrate pharmacist prescribing into routine care.
KW - Community pharmacy
KW - Non-medical prescribing
KW - Pharmacist
KW - Pharmacist prescribing
KW - Prescription
KW - Primary care
KW - Systematic review
UR - https://www.scopus.com/pages/publications/105051680969
U2 - 10.1016/j.rcsop.2026.100846
DO - 10.1016/j.rcsop.2026.100846
M3 - Article
SN - 2667-2766
VL - 24
JO - Exploratory Research in Clinical and Social Pharmacy
JF - Exploratory Research in Clinical and Social Pharmacy
M1 - 100846
ER -